Venn Life Sciences Holdings PLC Directorate Change (3562I)
21 Mars 2018 - 8:01AM
UK Regulatory
TIDMVENN
RNS Number : 3562I
Venn Life Sciences Holdings PLC
21 March 2018
21 March 2018
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Resignation of Director
Venn Life Sciences ("Venn") an Integrated Drug Development
Partner offering a combination of drug development expertise and
clinical trial design and management to pharmaceutical,
biotechnology and medical device organisations announces that
Jonathan Hartshorn is to step down from his position as Finance
Director of the Company with immediate effect.
Tony Richardson said "Jonathan is moving on to pursue other
opportunities. I would like to thank him for his contribution and
wish him well in his future endeavours". The Company will in due
course announce a permanent replacement but, in the meantime, the
finance function will report directly to the Chief Executive
Officer.
Enquiries:
Venn Life Sciences Holdings Plc
Allan Wood, Non-Executive Chairman
Tony Richardson, Chief Executive Officer Tel: +353 1 5499341
Cenkos (Nominated Advisor and Joint Tel: +44(0)20 3764 2341
Broker)
Mark Connelly/Steve Cox (Corporate Finance)
Davy (ESM Adviser and Joint Broker)
Fergal Meegan / Matthew de Vere Tel: +353 1 679 6363
White (Corporate Finance)
Hybridan LLP (Joint Broker) Tel: +44 (0)20 3764 2341
Claire Louise Noyce
About Venn Life Sciences: Venn Life Sciences is an Integrated
Drug Development Partner offering a unique combination of drug
development expertise and clinical trial design and management to
pharmaceutical, biotechnology and medical device organisations.
Venn have dedicated operations in France, Germany, the Netherlands,
the UK, Ireland with partners across Europe and the US.
Further information in relation to Venn Life Sciences
www.vennlifesciences.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABRGDXCDDBGIG
(END) Dow Jones Newswires
March 21, 2018 03:01 ET (07:01 GMT)
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024